BioCentury
ARTICLE | Company News

Revolution acquiring Warp Drive

October 19, 2018 5:40 PM UTC

Revolution Medicines Inc. (Redwood City, Calif.) is expanding its cancer pipeline with the acquisition of another Third Rock Ventures portfolio company, Warp Drive Bio Inc. (Cambridge, Mass.). The financial terms of the deal are undisclosed beyond noting that Warp Drive investors will receive stock in Revolution.

"When we put these two pipelines together, we end up with very comprehensive and deep coverage of the RAS oncogenic pathway," President and CEO Mark Goldsmith told BioCentury...